Understanding the Safety Concerns of Compounded GLP-1 Therapies The primary concern when evaluating compounded GLP-1 clinical safety is product quality, consistency, and manufacturing oversight
BMI Between 27 and 30 (Overweight) + a Weight-Related Condition If your BMI falls between 27 and 30, you may qualify for Mounjaro if you have a weight-related health condition, such as: Hypertension (high blood pressure) Dyslipidemia (abnormal levels of cholesterol or other fats in the blood) Obstructive sleep apnea Diabetes Check Your Eligibility at The Care Pharmacy Not everyone who is overweight or has PCOS will be suitable for Mounjaro
still, Ozempic carries a boxed warning and is not recommended for those with a personal or family history of medullary thyroid carcinoma or MEN2
Urbina J, Salinas-Ruiz LE, Valenciano C, Clapp B
Nutritional Support: For those taking GLP-1s, its crucial that as their caloric intake decreases, they have sufficient nutritional intake
This means that the US Food and Drug Administration has flagged the drug and that it should be taken with serious caution